InvestorsHub Logo
Post# of 252477
Next 10
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

Re: ThomasS post# 53479

Monday, 10/15/2007 9:05:06 PM

Monday, October 15, 2007 9:05:06 PM

Post# of 252477
RPRX

In case anyone was wondering, this is a big fat score for Repros. There is no doubt in anyone's mind that this drug is effective in raising testosterone...the P value for the last trial had a bunch o'zeros after the dot.

This makes Androxal an eminently partnerable product. Or an outright sale of the entire program could be in the cards.

I'm rarely this enthusiastic, but fact is this drug works and it works well. I don't think there are any significant safety concerns either, at least compared with testosterone gels--by all accounts it should be safer. Of course, there is always the concern about unmasking prostate cancer, but that concern will exist for any product modifying testosterone levels.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.